A role for protease activity and host-cell permeability during the process of Trypanosoma cruzi egress from infected cells

Journal of Parasitology

Volumn 93, Issue 6, 2007, Pages 1350-1359

  Costales, Jaime ^a,b   Rowland, Edwin C ^a  

^a OHIO UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DYE; PROTEINASE;

CELL ORGANELLE; ENZYME ACTIVITY; MEMBRANE; PARASITE; PLASMA; PROTOZOAN;

CELL DIVISION; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CONFERENCE PAPER; ENZYME ACTIVITY; HOST CELL; NONHUMAN; PARASITE; TRYPANOSOMA CRUZI; WESTERN BLOTTING;

ALPHA 1-ANTITRYPSIN; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELL MEMBRANE PERMEABILITY; COLORING AGENTS; CYSTEINE ENDOPEPTIDASES; CYSTEINE PROTEINASE INHIBITORS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; FIBROBLASTS; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; IMMUNE SERA; IMMUNOPRECIPITATION; MICE; MICE, INBRED BALB C; NEURAMINIDASE; PEPTIDE HYDROLASES; TRYPAN BLUE; TRYPANOSOMA CRUZI;

MUS; TRYPANOSOMA CRUZI;

EID: 38849209244     PISSN: 00223395     EISSN: None     Source Type: Journal    
DOI: 10.1645/GE-1074.1     Document Type: Conference Paper

References (34)

1. ANDREWS, N. W., C. K. ABRAMS, S. L. SLATIN, AND G. GRIFFITHS. 1990. A T. cruzi-secreted protein immunologically related to the complement component C9: Evidence for membrane pore-forming activity at low pH. Cell 61: 1277-1287.
2. BANNISTER, L. H. 2001. Looking for the exit: How do malaria parasites escape from red blood cells? Proceedings of the National Academy of Science of the United States of America 98: 383-384.
3. BERASAIN, P., C. CARMONA, B. FRANGIONE, J. J. CAZZULO, AND F. GOÑI. 2003. Specific cleavage sites on human IgG subclasses by cruzipain, the major cysteine proteinase from Trypanosoma cruzi. Molecular and Biochemical Parasitology 130: 23-29.
4. BLACK, M. W., G. ARRIZABALAGA, AND J. C. BOOTHROYD. 2000. Ionophore-resistant mutants of Toxoplasma gondii reveal host cell permeabilization as an early event in egress. Molecular and Cellular Biology 20: 9399-9408.
5. BORRIELLO, F., AND K. S. KRAUTER. 1991. Multiple murine alpha 1-protease inhibitor genes show unusual evolutionary divergence. Proceedings of the National Academy of Sciences of the United States of America 88: 9417-9421.
6. BUCKNER, F. S., AND W. C. V. VOORHIS. 2000. Immune response to Trypanosoma cruzi: Control of infection and pathogenesis of Chagas disease. In Effects of microbes in the immune system, M. W. Cunningham and R. S. Fujinami (eds.). Lipincott Williams & Wilkins, Philadelphia, Pennsylvania, p. 569-592.
7. BURLEIGH, B. A., AND A. M. WOOLSEY. 2002. Cell signaling and Trypanosoma cruzi invasion. Cellular Microbiology 4: 701-711.
8. COAKLEY, R. J., C. TAGGART, S. O'NEILL, AND N. G. MCELVANEY. 2001. Alpha1-antitrypsin deficiency: Biological answers to clinical questions. The American Journal of the Medical Sciences 321: 33-41.
9. ENGEL, J. C., P. S. DOYLE, J. PALMER, I. HSIEH, D. F. BAINTON, AND J. H. MCKERROW. 1998. Cysteine protease inhibitors alter Golgi complex ultrastructure and function in Trypanosoma cruzi. Journal of Cell Science 111: 597-606.
10. FISCHER, E., M. A. OUASSI, P. VELGE, J. CORNETTE, AND M. D. KAZATCHKINE. 1988. gp58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway. Immunology 65: 299-303.
11. GETTINS, P. G. W. 2002. Serpin structure, mechanism and function. Chemical Reviews 102: 4751-4803.
12. _, K. J. GOODRUM, AND E. C. ROWLAND. 1999. Immunological characterization of antigens released by Trypanosoma cruzi infected cells. Journal of Parasitology 85: 663-671.
13. GRIJALVA, M. J., E. C. ROWLAND, M. R. POWELL, T. S. MCCORMICK, AND L. ESCALANTE. 1995. Blood donors in a vector-free zone of Ecuador potentially infected with Trypanosoma cruzi. American Journal of Tropical Medicine and Hygiene 52: 360-363.
14. GRUPPI, A., F. M. CERBAN, AND E. VOTTERO- CIMA. 1997. Exoantigens from Trypanosoma cruzi contain cruzipain. Acta Tropica 63: 141-149.
15. HANSPAL, M., M. DUA, Y. TAKAKUWA, A. H. CHISHTI, AND A. MIZUNO. 2002. Plasmodium falciparum cysteine protease falcipain-2 cleaves erythrocyte membrane skeletal proteins at late stages of parasite development. Blood 100: 1048-1054.
16. HARTH, G., N. ANDREWS, A. A. MILLS, J. C. ENGEL, R. SMITH, AND J. H. MCKERROW. 1993. Peptide-fluoromethyl ketones arrest intracellular replication and intercellular transmission of Trypanosoma cruzi. Molecular and Biochemical Parasitology 58: 17-24.
17. HERMAN, B., A. L. NIEMINEN, G. J. GORES, AND J. J. LEMASTERS. 1988. Irreversible injury in anoxic hepatocytes precipitated by an abrupt increase in plasma membrane permeability. FASEB Journal 2: 146-151.
18. JOINER, K., W. DIAS DA SILVA, M. RIMOLDI, C. HAMMER, A. SHER, AND T. KIPNIS. 1988. Biochemical characterization of a factor produced by trypomastigotes of Trypanosoma cruzi that accelerates the decay of complement C3 convertases. Journal of Biological Chemistry 263: 11327-11335.
19. MOORE-LAI, D., AND E. C. ROWLAND. 2004a. Antiegressin acts late in the intracellular growth cycle of Trypanosoma cruzi to inhibit parasite egress. Journal of Parasitology 90: 85-91.
20. _, AND _. 2004b. Discovery and characterization of an antibody, anti-egressin, that is able to inhibit Trypanosoma cruzi egress in vitro. Journal of Parasitology 90: 524-530.
21. MOTTRAM, J. C., D. R. BROOKS, AND G. H. COOMBS. 1998. Roles of cysteine proteinases of trypanosomes and Leishmania in host-parasite interactions. Current Opinion in Microbiology 1: 455-460.
22. NORRIS, K. A., B. BRADT, N. R. COOPER, AND M. SO. 1991. Characterization of a Trypanosoma cruzi C3 binding protein with functional and genetic similarities to the complement regulatory protein, decay accelerating factor. Journal of Immunology 147: 2240-2247.
23. PAULINO, M., F. IRIBARNE, M. DUBIN, S. AGUILERA-MORALES, O. TAPIA, AND A. O. STOPPANI. 2005. The chemotherapy of Chagas' disease: An overview. Mini Reviews in Medicinal Chemistry 5: 499-519.
24. PRATA, A. 2001. Clinical and epidemiological aspects of Chagas disease. The Lancet Infectious Diseases 1: 92-100.
25. ROSFJORD, E. C., K. S. MIKHAIL, E. C. ROWLAND, AND M. R. POWELL. 1990. Analysis of antibody cross-reactivity in experimental American trypanosomiasis. Journal of Parasitology 76: 698-702.
26. ROWLAND, E. C., AND Z. CHEN. 2003. Inhibition of Trypanosoma cruzi egress from infected fibroblasts is mediated by CD4+ and μ+ immune cells. Journal of Parasitology 89: 733-737.
27. SCHARFSTEIN, J., M. SCHECHTER, M. SENNA, J. M. PERALTA, L. MENDONCA-PREVIATO, AND M. A. MILES. 1986. Trypanosoma cruzi: Characterization and isolation of a 57/51,000 m.w. surface glycoprotein (GP57/51) expressed by epimastigotes and bloodstream trypomastigotes. Journal of Immunology 137: 1336-1341.
28. 2 receptors. Journal of Experimental Medicine 192: 1289-1300.
29. TAYLOR, G. 1996. Sialidases: Structures, biological significance and therapeutic potential. Current Opinion in Structural Biology 6: 830-837.
30. THOMAS, S. L., AND V. L. LEW. 2004. Plasmodium falciparum and the permeation pathway of the host red blood cell. Trends in Parasitology 20: 122-125.
31. TYLER, K. M., AND D. M. ENGMAN. 2001. The life cycle of Trypanosoma cruzi revisited. International Journal for Parasitology 31: 472-481.
32. 1 in Trypanosoma cruzi: An enzyme with a possible role in pathogenesis of Chagas' disease. The Biochemical Journal 355: 765-770.
33. WOOLSEY, A. M., L. SUNWOO, C. A. PETERSEN, S. M. BRACHMANN, L. C. CANTLEY, AND B. A. BURLEIGH. 2003. Novel PI 3-kinase-dependent mechanism of trypanosome invasion and vacuole maturation. Journal of Cell Science 116: 3611-3622.
34. WORLD HEALTH ORGANIZATION (WHO). 2002. Control of Chagas disease. Technical report series, No. 905. World Health Organization, Geneva, Switzerland, p. 5-14.